Skip to main content

Advertisement

SpringerLink
Log in

The impact of type 2 diabetes on the outcome of localized renal cell carcinoma

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the influence of type 2 diabetes on cancer-specific outcome in patients undergoing surgery for localized renal cell carcinoma (RCC).

Methods

A total of 1,140 patients with localized RCC undergoing radical or partial nephrectomy were enrolled into this retrospective case–control study. Primary outcome was the cancer-specific survival comparing patients with and without type 2 diabetes at the time of surgery. Secondary outcomes were recurrence-free survival and metastases-free survival comparing the same groups. Additionally, the influence of accompanying factors on cancer-specific survival and overall survival of patients was evaluated in a multivariate analysis. Among 1,140 patients included in the analyses, 202 had diabetes at the time of surgery and 938 patients without diabetes served as control.

Results

The univariate comparisons between patients with and without diabetes regarding recurrence-free, metastases-free, and cancer-specific survival revealed no significant differences. Multivariate results demonstrate that age, BMI, and diabetes had no significant effect on cancer-specific hazard among participants. After adjustment of the factors in terms of overall survival, however, increased age, increased BMI, and type 2 diabetes at the time of surgery were independent risk factors for the occurrence of the event death.

Conclusions

Type 2 diabetes and obesity at the time of surgery have no significant impact on cancer-specific and recurrence-free survival in patients with localized renal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578. doi:10.1016/S0140-6736(08)60269-X

    Article  PubMed  Google Scholar 

  2. Smyth S, Heron A (2006) Diabetes and obesity: the twin epidemics. Nat Med 12(1):75–80. doi:10.1038/nm0106-75

    Article  CAS  PubMed  Google Scholar 

  3. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60(4):207–221. doi:10.3322/caac.20078

    Article  PubMed  Google Scholar 

  4. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300(23):2754–2764. doi:10.1001/jama.2008.824

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378(9785):31–40. doi:10.1016/S0140-6736(11)60679-X

    Article  CAS  PubMed  Google Scholar 

  6. Xu X, Wu J, Mao Y, Zhu Y, Hu Z, Lin Y, Chen H, Zheng X, Qin J, Xie L (2013) Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. PLoS ONE 8(3):e58079. doi:10.1371/journal.pone.0058079

    Article  PubMed Central  PubMed  Google Scholar 

  7. Lawrence YR, Morag O, Benderly M, Boyko V, Novikov I, Dicker AP, Goldbourt U, Behar S, Barchana M, Wolf I (2013) Association between metabolic syndrome, diabetes mellitus and prostate cancer risk. Prostate Cancer Prostatic Dis. doi:10.1038/pcan.2012.54

    PubMed  Google Scholar 

  8. Fall K, Garmo H, Gudbjornsdottir S, Stattin P, Zethelius BO (2013) Diabetes mellitus and prostate cancer risk: a nationwide case–control study within PCBASE Sweden. Cancer Epidemiol Biomarkers Prev. doi:10.1158/1055-9965.EPI-12-1046

    PubMed Central  Google Scholar 

  9. Lee S, Hong SK, Kwak C, Kim HH, Lee SE (2012) Prognostic significance of diabetes mellitus in localized renal cell carcinoma. Jpn J Clin Oncol 42(4):318–324. doi:10.1093/jjco/hys018

    Article  PubMed  Google Scholar 

  10. Antonelli A, Arrighi N, Corti S, Zanotelli T, Cozzoli A, Cosciani Cunico S, Simeone C (2012) Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study. Urol Oncol. doi:10.1016/j.urolonc.2011.12.013

    Google Scholar 

  11. Huber J, Herpel E, Jakobi H, Hadaschik BA, Pahernik S, Hohenfellner M (2012) Two decades’ experience with a prospective biobank for urologic oncology: research, clinical care, and the patients’ view. Urol Oncol. doi:10.1016/j.urolonc.2012.01.016

    PubMed  Google Scholar 

  12. Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in cox regression. Stat Med 14(15):1707–1723

    Article  CAS  PubMed  Google Scholar 

  13. Ha YS, Kim WT, Yun SJ, Lee SC, Kim WJ, Park YH, Kang SH, Hong SH, Byun SS, Kim YJ (2013) Multi-institutional analysis of localized renal cell carcinoma that demonstrates the impact of diabetic status on prognosis after nephrectomy. Ann Surg Oncol 20(11):3662–3668. doi:10.1245/s10434-013-3147-7

    Article  PubMed  Google Scholar 

  14. Suer E, Ozturk E, Gulpinar O, Kayis A, Baltaci S (2013) Effect of type 2 diabetes mellitus on prognosis of nonmetastatic renal cell cancer. Korean J Urol 54(8):499–503. doi:10.4111/kju.2013.54.8.499

    Article  PubMed Central  PubMed  Google Scholar 

  15. Fukushima H, Masuda H, Yokoyama M, Tatokoro M, Yoshida S, Ishioka J, Matsuoka Y, Numao N, Koga F, Saito K, Fujii Y, Kihara K (2013) Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma. Jpn J Clin Oncol 43(7):740–746. doi:10.1093/jjco/hyt070

    Article  PubMed  Google Scholar 

  16. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njolstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364(9):829–841. doi:10.1056/NEJMoa1008862

    Article  CAS  PubMed  Google Scholar 

  17. Brower V (2012) Illuminating the diabetes–cancer link. J Natl Cancer Inst 104(14):1048–1050. doi:10.1093/jnci/djs322

    Article  PubMed  Google Scholar 

  18. Ferrannini E, Cushman WC (2012) Diabetes and hypertension: the bad companions. Lancet 380(9841):601–610. doi:10.1016/S0140-6736(12)60987-8

    Article  PubMed  Google Scholar 

  19. Ito K, Nakashima J, Hanawa Y, Oya M, Ohigashi T, Marumo K, Murai M (2004) The prediction of renal function 6 years after unilateral nephrectomy using preoperative risk factors. J Urol 171(1):120–125. doi:10.1097/01.ju.0000100981.11470.2f

    Article  PubMed  Google Scholar 

  20. Kodama S, Tanaka S, Heianza Y, Fujihara K, Horikawa C, Shimano H, Saito K, Yamada N, Ohashi Y, Sone H (2013) Association between physical activity and risk of all-cause mortality and cardiovascular disease in patients with diabetes: a meta-analysis. Diabetes Care 36(2):471–479. doi:10.2337/dc12-0783

    Article  PubMed Central  PubMed  Google Scholar 

  21. Habib SL, Prihoda TJ, Luna M, Werner SA (2012) Diabetes and risk of renal cell carcinoma. J Cancer 3:42–48. doi:10.7150/jca.3718

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Hellemons ME, Kerschbaum J, Bakker SJ, Neuwirt H, Mayer B, Mayer G, de Zeeuw D, Lambers Heerspink HJ, Rudnicki M (2012) Validity of biomarkers predicting onset or progression of nephropathy in patients with type 2 diabetes: a systematic review. Diabet Med 29(5):567–577. doi:10.1111/j.1464-5491.2011.03437.x

    Article  CAS  PubMed  Google Scholar 

  23. Abouassaly R, Finelli A, Tomlinson GA, Urbach DR, Alibhai SM (2011) How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population-based analysis. BJU Int 108(11):1806–1812. doi:10.1111/j.1464-410X.2011.10254.x

    Article  PubMed  Google Scholar 

  24. Filson CP, Schwartz K, Colt JS, Ruterbusch J, Linehan WM, Chow WH, Miller DC (2013) Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension. Urol Oncol. doi:10.1016/j.urolonc.2012.09.014

    PubMed Central  Google Scholar 

  25. Stolarczyk E, Vong CT, Perucha E, Jackson I, Cawthorne MA, Wargent ET, Powell N, Canavan JB, Lord GM, Howard JK (2013) Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet. Cell Metab 17(4):520–533. doi:10.1016/j.cmet.2013.02.019

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Liew CW, Boucher J, Cheong JK, Vernochet C, Koh HJ, Mallol C, Townsend K, Langin D, Kawamori D, Hu J, Tseng YH, Hellerstein MK, Farmer SR, Goodyear L, Doria A, Bluher M, Hsu SI, Kulkarni RN (2013) Ablation of TRIP-Br 2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nat Med 19(2):217–226. doi:10.1038/nm.3056

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Rose S, Laan MJ (2009) Why match? Investigating matched case–control study designs with causal effect estimation. Int J Biostat 5 (1): Article 1. doi:10.2202/1557-4679.1127

  28. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11–30. doi:10.3322/caac.21166

    Article  PubMed  Google Scholar 

  29. Grimes DA, Schulz KF (2005) Compared to what? Finding controls for case–control studies. Lancet 365(9468):1429–1433. doi:10.1016/S0140-6736(05)66379-9

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Urology, University Hospital Heidelberg, Heidelberg, Germany

    Thomas Höfner, Gencay Hatiboglu, Gita Schönberg, Boris Hadaschik, Dogu Teber, Stefan Duensing, Markus Hohenfellner & Sascha Pahernik

  2. Kidney Center, University Hospital Heidelberg, Heidelberg, Germany

    Martin Zeier

  3. Division of Stem Cells and Cancer, Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH (HI-STEM), Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany

    Christian Eisen & Andreas Trumpp

Authors
  1. Thomas Höfner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Zeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gencay Hatiboglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christian Eisen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gita Schönberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Boris Hadaschik
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dogu Teber
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Stefan Duensing
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Andreas Trumpp
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Markus Hohenfellner
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sascha Pahernik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sascha Pahernik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Höfner, T., Zeier, M., Hatiboglu, G. et al. The impact of type 2 diabetes on the outcome of localized renal cell carcinoma. World J Urol 32, 1537–1542 (2014). https://doi.org/10.1007/s00345-013-1231-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-013-1231-z

Keywords

Search

Navigation